Presence of morphine metabolites in human cerebrospinal fluid after intracerebroventricular administration of morphine.
After intracerebroventricular administration of morphine in four cancer patients, cerebrospinal fluid (CSF) was analyzed by two morphine radioimmunoassays (RIA), liquid chromatography (LC) and radioreceptor assay (RRA) to evaluate the presence of morphine metabolites. Immunoreactive morphine-like substances were detected by differential RIA's. The maximum concentrations of these compounds were achieved 3 hours after drug administration. These concentrations, according to the specificity of the antiserum, represent a mixture of several metabolites in which only morphine 3-glucuronide(M 3-G) and morphine 6-glucuronide (M 6-G) were identified by LC, and M 6-G by LC-RRA. These results confirm that brain is able to metabolize morphine to inactive (M 3-G) or more potent (M 6-G) derivatives.
Sandouk
P
P
INSERM U.26, Laboratoire de Neurotoxicologie, Hôpital Fernand Widal, Paris, France.
Serrie
A
A
Scherrmann
J M
JM
Langlade
A
A
Bourre
J M
JM
D002853:Chromatography, Liquid; D006801:Humans; D007276:Injections, Intraventricular; D008297:Male; D009020:Morphine / Q000008:administration & dosage / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics*; D009022:Morphine Derivatives / Q000134:cerebrospinal fluid; D010148:Intractable Pain / Q000188:drug therapy; D011863:Radioimmunoassay; D011869:Radioligand Assay
D009022:Morphine Derivatives; C035349:morphine-6-glucuronide; D009020:Morphine; C018108:morphine-3-glucuronide